chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy
Clinical narrative: Bell's palsy
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, COVID-19, Exposure during pregnancy, SARS-CoV-2 test positive, Thrombosis
Clinical narrative: I was 9 weeks pregnant when I had my first COVID vaccine on Aug 24.  My estimated due date was March 22, 2022. I started spotting 11 days after the vaccine, on Sep 4. The spotting gradually increased. Two days later to large blood clots and the blood loss was so much that I went to the ER. I miscarried  on Sep 6 at 11 weeks pregnant. A D&C procedure was performed to complete the tissue removal. A blood transfusion was thought to be necessary but I did not end up having one.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: I was 9 weeks pregnant when I had my first COVID vaccine on Aug 24.  My estimated due date was March 22, 2022. I started spotting 11 days after the vaccine, on Sep 4. The spotting gradually increased. Two days later to large blood clots and the blood loss was so much that I went to the ER. I miscarried  on Sep 6 at 11 weeks pregnant. A D&C procedure was performed to complete the tissue removal. A blood transfusion was thought to be necessary but I did not end up having one.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Cardiac stress test, Cardiac therapeutic procedure, Cough
Clinical narrative: Became weak and progressed into a constant cough, migraines that needed Tylenol with codeine. High blood pressure and pulse at 160/113 and pulse at 100 was constant. After tons of various medical tests an mri was done on my heart in sept 2021. Scar tissue was found on my heart from Myocarditis
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Magnetic resonance imaging, Migraine, Myocarditis, X-ray
Clinical narrative: Became weak and progressed into a constant cough, migraines that needed Tylenol with codeine. High blood pressure and pulse at 160/113 and pulse at 100 was constant. After tons of various medical tests an mri was done on my heart in sept 2021. Scar tissue was found on my heart from Myocarditis
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Ear discomfort, Ear pain, Erythema, Fatigue
Clinical narrative: Syncope within 10 minutes of injection  requiring assistance and inability to stand or  walk for extended period of time Hear palpitations, tinnitus which has not dissipated, ear pressure and pain Right arm pain, swelling, redness, stiffness, pain radiating down the arm Severe headache like none ever before for over two weeks, beginning to subside - did not dissipate with over the counter pain relievers Exhaustion Muscle pain Nausea
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Headache, Musculoskeletal stiffness, Myalgia, Nausea
Clinical narrative: Syncope within 10 minutes of injection  requiring assistance and inability to stand or  walk for extended period of time Hear palpitations, tinnitus which has not dissipated, ear pressure and pain Right arm pain, swelling, redness, stiffness, pain radiating down the arm Severe headache like none ever before for over two weeks, beginning to subside - did not dissipate with over the counter pain relievers Exhaustion Muscle pain Nausea
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Palpitations, Swelling, Syncope
Clinical narrative: Syncope within 10 minutes of injection  requiring assistance and inability to stand or  walk for extended period of time Hear palpitations, tinnitus which has not dissipated, ear pressure and pain Right arm pain, swelling, redness, stiffness, pain radiating down the arm Severe headache like none ever before for over two weeks, beginning to subside - did not dissipate with over the counter pain relievers Exhaustion Muscle pain Nausea
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Syncope within 10 minutes of injection  requiring assistance and inability to stand or  walk for extended period of time Hear palpitations, tinnitus which has not dissipated, ear pressure and pain Right arm pain, swelling, redness, stiffness, pain radiating down the arm Severe headache like none ever before for over two weeks, beginning to subside - did not dissipate with over the counter pain relievers Exhaustion Muscle pain Nausea
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Anticoagulant therapy, Anxiety, Arthralgia
Clinical narrative: Deceased (9.26.21);  Hospitalized due to COVID-19 (9.2.21);  COVID-19 positive (8.31.21);  Fully vaccinated   Admission Date: 9/2/2021 Died 9/26/21 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] Pneumonia due to COVID-19 virus [U07.1, J12.82] Acute hypoxemic respiratory failure (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 65 y.o. female with a PMHx of COPD not on home oxygen, HTN, Hypothyroid, RA on immunomodulator therapy who was admitted for AHRF secondary to Covid pneumonia. Completed 4 days of dexamethasone, 3 days of remdesivir so far. Bcx, other infectious work-up have been negative. Going intermittently between HFNC and BiPAP, stays relatively comfortable without additional work of breathing. She has been responding well to once/day diuresis. Multiple conversations at that time were held with the patient, who has elected to be DNR/DNI - okay with vasopressor medications if needed. After transfer out of the ICU she completed dexamethasone, remdesivir, diuresis as needed- she developed an AkI that resolved. She was able to alternate between HFNC and BiPAP but developed hypoxia despite continuous BiPAP at 100%. She was readmitted to the ICU on 9/11 and was unsure of her code status to be DNR or FULL. Overnight she remained on continuous BiPAP with O2 sats in the high 80s. A CTA to rule out PE was unable to be performed given her respiratory status, U/S showed no signsof DVT. On 9/12 Patient had increased work of breathing and anxiety, especially with repositioning and requested to be FULL CODE and was electively intubated for hypoxic respiratory failure 2/2 COVID-19 PNA.    Following intubation, the patient did develop worsening urine output and AKI.  She ultimately was started on CRRT for volume overload.  With volume overload, her O2 requirement did improve somewhat, but she still had significant ventilatory needs due to her COVID-19 pneumonia.  Patient also had persistent tachycardia during her hospital stay.  Her serotonergic medications were held to rule out serotonin syndrome, repeat cultures were obtained without any growth, and extremity ultrasounds were performed which did show equivocal left coronal DVT.  Patient was started on heparin drip for this possible DVT.   Due to the persistent high ventilatory needs, goals of care were discussed with the family.  It was agreed that tracheostomy tube placement was not in line with the patient's goals of care, and due to her persistent refractory hypoxemia requiring high ventilatory needs, plan was made to transition patient to comfort care on Monday, 09/27/2021. On Sunday 9/26 patient had acute worsening in clinical status with decreasing oxygen levels. Based on patient's families wishes for the patient to be with her husband upon passing the patient was made comfort care and passed away at 1108 AM. Date of Death: 9/26/21 Time of Death: 11:08 AM Preliminary Cause of Death: COVID-19
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood culture negative, Bursitis, COVID-19, COVID-19 pneumonia, Coronary artery thrombosis
Clinical narrative: Deceased (9.26.21);  Hospitalized due to COVID-19 (9.2.21);  COVID-19 positive (8.31.21);  Fully vaccinated   Admission Date: 9/2/2021 Died 9/26/21 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] Pneumonia due to COVID-19 virus [U07.1, J12.82] Acute hypoxemic respiratory failure (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 65 y.o. female with a PMHx of COPD not on home oxygen, HTN, Hypothyroid, RA on immunomodulator therapy who was admitted for AHRF secondary to Covid pneumonia. Completed 4 days of dexamethasone, 3 days of remdesivir so far. Bcx, other infectious work-up have been negative. Going intermittently between HFNC and BiPAP, stays relatively comfortable without additional work of breathing. She has been responding well to once/day diuresis. Multiple conversations at that time were held with the patient, who has elected to be DNR/DNI - okay with vasopressor medications if needed. After transfer out of the ICU she completed dexamethasone, remdesivir, diuresis as needed- she developed an AkI that resolved. She was able to alternate between HFNC and BiPAP but developed hypoxia despite continuous BiPAP at 100%. She was readmitted to the ICU on 9/11 and was unsure of her code status to be DNR or FULL. Overnight she remained on continuous BiPAP with O2 sats in the high 80s. A CTA to rule out PE was unable to be performed given her respiratory status, U/S showed no signsof DVT. On 9/12 Patient had increased work of breathing and anxiety, especially with repositioning and requested to be FULL CODE and was electively intubated for hypoxic respiratory failure 2/2 COVID-19 PNA.    Following intubation, the patient did develop worsening urine output and AKI.  She ultimately was started on CRRT for volume overload.  With volume overload, her O2 requirement did improve somewhat, but she still had significant ventilatory needs due to her COVID-19 pneumonia.  Patient also had persistent tachycardia during her hospital stay.  Her serotonergic medications were held to rule out serotonin syndrome, repeat cultures were obtained without any growth, and extremity ultrasounds were performed which did show equivocal left coronal DVT.  Patient was started on heparin drip for this possible DVT.   Due to the persistent high ventilatory needs, goals of care were discussed with the family.  It was agreed that tracheostomy tube placement was not in line with the patient's goals of care, and due to her persistent refractory hypoxemia requiring high ventilatory needs, plan was made to transition patient to comfort care on Monday, 09/27/2021. On Sunday 9/26 patient had acute worsening in clinical status with decreasing oxygen levels. Based on patient's families wishes for the patient to be with her husband upon passing the patient was made comfort care and passed away at 1108 AM. Date of Death: 9/26/21 Time of Death: 11:08 AM Preliminary Cause of Death: COVID-19
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Culture negative, Death, Dyspnoea, Endotracheal intubation, General physical health deterioration
Clinical narrative: Deceased (9.26.21);  Hospitalized due to COVID-19 (9.2.21);  COVID-19 positive (8.31.21);  Fully vaccinated   Admission Date: 9/2/2021 Died 9/26/21 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] Pneumonia due to COVID-19 virus [U07.1, J12.82] Acute hypoxemic respiratory failure (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 65 y.o. female with a PMHx of COPD not on home oxygen, HTN, Hypothyroid, RA on immunomodulator therapy who was admitted for AHRF secondary to Covid pneumonia. Completed 4 days of dexamethasone, 3 days of remdesivir so far. Bcx, other infectious work-up have been negative. Going intermittently between HFNC and BiPAP, stays relatively comfortable without additional work of breathing. She has been responding well to once/day diuresis. Multiple conversations at that time were held with the patient, who has elected to be DNR/DNI - okay with vasopressor medications if needed. After transfer out of the ICU she completed dexamethasone, remdesivir, diuresis as needed- she developed an AkI that resolved. She was able to alternate between HFNC and BiPAP but developed hypoxia despite continuous BiPAP at 100%. She was readmitted to the ICU on 9/11 and was unsure of her code status to be DNR or FULL. Overnight she remained on continuous BiPAP with O2 sats in the high 80s. A CTA to rule out PE was unable to be performed given her respiratory status, U/S showed no signsof DVT. On 9/12 Patient had increased work of breathing and anxiety, especially with repositioning and requested to be FULL CODE and was electively intubated for hypoxic respiratory failure 2/2 COVID-19 PNA.    Following intubation, the patient did develop worsening urine output and AKI.  She ultimately was started on CRRT for volume overload.  With volume overload, her O2 requirement did improve somewhat, but she still had significant ventilatory needs due to her COVID-19 pneumonia.  Patient also had persistent tachycardia during her hospital stay.  Her serotonergic medications were held to rule out serotonin syndrome, repeat cultures were obtained without any growth, and extremity ultrasounds were performed which did show equivocal left coronal DVT.  Patient was started on heparin drip for this possible DVT.   Due to the persistent high ventilatory needs, goals of care were discussed with the family.  It was agreed that tracheostomy tube placement was not in line with the patient's goals of care, and due to her persistent refractory hypoxemia requiring high ventilatory needs, plan was made to transition patient to comfort care on Monday, 09/27/2021. On Sunday 9/26 patient had acute worsening in clinical status with decreasing oxygen levels. Based on patient's families wishes for the patient to be with her husband upon passing the patient was made comfort care and passed away at 1108 AM. Date of Death: 9/26/21 Time of Death: 11:08 AM Preliminary Cause of Death: COVID-19
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypervolaemia, Intensive care, Laboratory test normal, Lumbar radiculopathy, Mechanical ventilation
Clinical narrative: Deceased (9.26.21);  Hospitalized due to COVID-19 (9.2.21);  COVID-19 positive (8.31.21);  Fully vaccinated   Admission Date: 9/2/2021 Died 9/26/21 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] Pneumonia due to COVID-19 virus [U07.1, J12.82] Acute hypoxemic respiratory failure (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 65 y.o. female with a PMHx of COPD not on home oxygen, HTN, Hypothyroid, RA on immunomodulator therapy who was admitted for AHRF secondary to Covid pneumonia. Completed 4 days of dexamethasone, 3 days of remdesivir so far. Bcx, other infectious work-up have been negative. Going intermittently between HFNC and BiPAP, stays relatively comfortable without additional work of breathing. She has been responding well to once/day diuresis. Multiple conversations at that time were held with the patient, who has elected to be DNR/DNI - okay with vasopressor medications if needed. After transfer out of the ICU she completed dexamethasone, remdesivir, diuresis as needed- she developed an AkI that resolved. She was able to alternate between HFNC and BiPAP but developed hypoxia despite continuous BiPAP at 100%. She was readmitted to the ICU on 9/11 and was unsure of her code status to be DNR or FULL. Overnight she remained on continuous BiPAP with O2 sats in the high 80s. A CTA to rule out PE was unable to be performed given her respiratory status, U/S showed no signsof DVT. On 9/12 Patient had increased work of breathing and anxiety, especially with repositioning and requested to be FULL CODE and was electively intubated for hypoxic respiratory failure 2/2 COVID-19 PNA.    Following intubation, the patient did develop worsening urine output and AKI.  She ultimately was started on CRRT for volume overload.  With volume overload, her O2 requirement did improve somewhat, but she still had significant ventilatory needs due to her COVID-19 pneumonia.  Patient also had persistent tachycardia during her hospital stay.  Her serotonergic medications were held to rule out serotonin syndrome, repeat cultures were obtained without any growth, and extremity ultrasounds were performed which did show equivocal left coronal DVT.  Patient was started on heparin drip for this possible DVT.   Due to the persistent high ventilatory needs, goals of care were discussed with the family.  It was agreed that tracheostomy tube placement was not in line with the patient's goals of care, and due to her persistent refractory hypoxemia requiring high ventilatory needs, plan was made to transition patient to comfort care on Monday, 09/27/2021. On Sunday 9/26 patient had acute worsening in clinical status with decreasing oxygen levels. Based on patient's families wishes for the patient to be with her husband upon passing the patient was made comfort care and passed away at 1108 AM. Date of Death: 9/26/21 Time of Death: 11:08 AM Preliminary Cause of Death: COVID-19
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation decreased, Positive airway pressure therapy, Rotator cuff repair, SARS-CoV-2 test positive, Tachycardia
Clinical narrative: Deceased (9.26.21);  Hospitalized due to COVID-19 (9.2.21);  COVID-19 positive (8.31.21);  Fully vaccinated   Admission Date: 9/2/2021 Died 9/26/21 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] Pneumonia due to COVID-19 virus [U07.1, J12.82] Acute hypoxemic respiratory failure (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 65 y.o. female with a PMHx of COPD not on home oxygen, HTN, Hypothyroid, RA on immunomodulator therapy who was admitted for AHRF secondary to Covid pneumonia. Completed 4 days of dexamethasone, 3 days of remdesivir so far. Bcx, other infectious work-up have been negative. Going intermittently between HFNC and BiPAP, stays relatively comfortable without additional work of breathing. She has been responding well to once/day diuresis. Multiple conversations at that time were held with the patient, who has elected to be DNR/DNI - okay with vasopressor medications if needed. After transfer out of the ICU she completed dexamethasone, remdesivir, diuresis as needed- she developed an AkI that resolved. She was able to alternate between HFNC and BiPAP but developed hypoxia despite continuous BiPAP at 100%. She was readmitted to the ICU on 9/11 and was unsure of her code status to be DNR or FULL. Overnight she remained on continuous BiPAP with O2 sats in the high 80s. A CTA to rule out PE was unable to be performed given her respiratory status, U/S showed no signsof DVT. On 9/12 Patient had increased work of breathing and anxiety, especially with repositioning and requested to be FULL CODE and was electively intubated for hypoxic respiratory failure 2/2 COVID-19 PNA.    Following intubation, the patient did develop worsening urine output and AKI.  She ultimately was started on CRRT for volume overload.  With volume overload, her O2 requirement did improve somewhat, but she still had significant ventilatory needs due to her COVID-19 pneumonia.  Patient also had persistent tachycardia during her hospital stay.  Her serotonergic medications were held to rule out serotonin syndrome, repeat cultures were obtained without any growth, and extremity ultrasounds were performed which did show equivocal left coronal DVT.  Patient was started on heparin drip for this possible DVT.   Due to the persistent high ventilatory needs, goals of care were discussed with the family.  It was agreed that tracheostomy tube placement was not in line with the patient's goals of care, and due to her persistent refractory hypoxemia requiring high ventilatory needs, plan was made to transition patient to comfort care on Monday, 09/27/2021. On Sunday 9/26 patient had acute worsening in clinical status with decreasing oxygen levels. Based on patient's families wishes for the patient to be with her husband upon passing the patient was made comfort care and passed away at 1108 AM. Date of Death: 9/26/21 Time of Death: 11:08 AM Preliminary Cause of Death: COVID-19
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ultrasound Doppler abnormal
Clinical narrative: Deceased (9.26.21);  Hospitalized due to COVID-19 (9.2.21);  COVID-19 positive (8.31.21);  Fully vaccinated   Admission Date: 9/2/2021 Died 9/26/21 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] Pneumonia due to COVID-19 virus [U07.1, J12.82] Acute hypoxemic respiratory failure (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 65 y.o. female with a PMHx of COPD not on home oxygen, HTN, Hypothyroid, RA on immunomodulator therapy who was admitted for AHRF secondary to Covid pneumonia. Completed 4 days of dexamethasone, 3 days of remdesivir so far. Bcx, other infectious work-up have been negative. Going intermittently between HFNC and BiPAP, stays relatively comfortable without additional work of breathing. She has been responding well to once/day diuresis. Multiple conversations at that time were held with the patient, who has elected to be DNR/DNI - okay with vasopressor medications if needed. After transfer out of the ICU she completed dexamethasone, remdesivir, diuresis as needed- she developed an AkI that resolved. She was able to alternate between HFNC and BiPAP but developed hypoxia despite continuous BiPAP at 100%. She was readmitted to the ICU on 9/11 and was unsure of her code status to be DNR or FULL. Overnight she remained on continuous BiPAP with O2 sats in the high 80s. A CTA to rule out PE was unable to be performed given her respiratory status, U/S showed no signsof DVT. On 9/12 Patient had increased work of breathing and anxiety, especially with repositioning and requested to be FULL CODE and was electively intubated for hypoxic respiratory failure 2/2 COVID-19 PNA.    Following intubation, the patient did develop worsening urine output and AKI.  She ultimately was started on CRRT for volume overload.  With volume overload, her O2 requirement did improve somewhat, but she still had significant ventilatory needs due to her COVID-19 pneumonia.  Patient also had persistent tachycardia during her hospital stay.  Her serotonergic medications were held to rule out serotonin syndrome, repeat cultures were obtained without any growth, and extremity ultrasounds were performed which did show equivocal left coronal DVT.  Patient was started on heparin drip for this possible DVT.   Due to the persistent high ventilatory needs, goals of care were discussed with the family.  It was agreed that tracheostomy tube placement was not in line with the patient's goals of care, and due to her persistent refractory hypoxemia requiring high ventilatory needs, plan was made to transition patient to comfort care on Monday, 09/27/2021. On Sunday 9/26 patient had acute worsening in clinical status with decreasing oxygen levels. Based on patient's families wishes for the patient to be with her husband upon passing the patient was made comfort care and passed away at 1108 AM. Date of Death: 9/26/21 Time of Death: 11:08 AM Preliminary Cause of Death: COVID-19
Age: 13.0
Sex: M
Vaccine: COVID19, HPV9, MMR, MNQ, TDAP
Symptoms: Back pain, Chest X-ray, Chest pain, Costochondritis, Electrocardiogram abnormal
Clinical narrative: Pateints mother called into our office (primary care) and reports the patient was given 5 vaccines at a local health dept the morning of 9/28/2021. Mother reports later that evening patient c/o chest pain and he was taken to a local ER. Mother reports her son had an abnormal EKG and also had a chest x-ray. The patient was dx with chest wall inflammation and sent home. Mother called our office on 9/30/2021 to schedule an ER f/u visit. She was concerned about her son still feeling abnormal and now has backpain. Advised his mother to take him back to the ER for reevaluation .
Age: 13.0
Sex: M
Vaccine: COVID19, HPV9, MMR, MNQ, TDAP
Symptoms: Feeling abnormal
Clinical narrative: Pateints mother called into our office (primary care) and reports the patient was given 5 vaccines at a local health dept the morning of 9/28/2021. Mother reports later that evening patient c/o chest pain and he was taken to a local ER. Mother reports her son had an abnormal EKG and also had a chest x-ray. The patient was dx with chest wall inflammation and sent home. Mother called our office on 9/30/2021 to schedule an ER f/u visit. She was concerned about her son still feeling abnormal and now has backpain. Advised his mother to take him back to the ER for reevaluation .
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea
Clinical narrative: I am an athletic person with no history of illness, no medications, or allergies.  I work out every day maybe missing a couple days a month.  I run and lift weights routinely.  Shortly after receiving my second dose of vaccine I began experiencing shortness of breath.  This SOB was not debilitating but has severely affected my ability to job.  I ran 10 miles just this spring.  I used to be able to run without any problem with my lungs.  My legs would be what tires out.  But now I struggle to run 3 miles.  Over the last month as I've picked up running more as it gets cooler in the morning, I have found my abilities significantly changed.  I used to be able to run a consistent 8 1/2 minute mile but, my run yesterday, I averaged 9 1/2 minutes per mile and struggled to complete 3 miles.  And that 3 miles was an improvement over the last month where I'd have to walk after 2 - 2 1/2 miles.  My Smart Watch tracks my estimated VO2Max which shows a drop at the beginning of August when I received my second dose of Pfizer COVID vaccine.  This shortness of breath will persist for some time after I am done exercising (either cardio or weight lifting) and feels like I can't take breaths that are deep enough.  Sometimes I feel light headed.  Many times I will be sitting at my desk working and will experience the same symptoms.  I used to experience symptoms like this periodically 12-20 years ago when I was overweight and a smoker.  I quit smoking  over 10 years ago and hadn't experienced symptoms like this since then.  They started just a couple of days after getting the vaccine.  Nothing else, that I can think of, happened around this time.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Eye pain, Hyperacusis, Listless, Mobility decreased
Clinical narrative: Chills, very sore L arm to point of uselessness, night sweat, tears, sore/painful eyes, listlessness, sound sensitivity.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Night sweats, Pain in extremity, Tearfulness
Clinical narrative: Chills, very sore L arm to point of uselessness, night sweat, tears, sore/painful eyes, listlessness, sound sensitivity.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abnormal dreams, Burning sensation, Chest pain, Decreased appetite, Insomnia
Clinical narrative: Patient called and left a phone message for the VP of a clinic on 09/30/2021.   I was able to retunr his call on 09/30/2021 at 6pm.  He stated that after receiving the 1st COVID  vaccine he left the event place and got a cup of coffee.  He said the coffee didn't taste the same as usual, and this was his first symptom.  He had no other symptoms, so he returned and took at 2nd COVID vaccine on 02/26/21.   He stated approximately 30 days after the 2nd vaccine his symptoms began exacerbating.  He experienced loss of appetite, eventually losing more than 12 pounds.   He reported 30 days after the 2nd vaccine he had trouble sleeping at night, crazy dreams.  He also said he had a burning sensation from his chest down to his pelvic area- an intense internal heat, and he was not febrile by the thermometer.   He states he has spent thousands of dollars going to doctors and specialists and he still doesn't have an answer to what is going on.  He told me all of his tests and lab works have been negative- he could not tell me what tests or labs he had done.  He did state he is feeling better.  I told him not to take the 3rd booster vaccine until he had been cleared to do so by his physician.   I also encouraged him to report this on VAERS and provided him with the website address.   I have alerted the Quality person of this event.  The evens that patient received were at our system's hospitals community events.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Laboratory test normal, Weight decreased
Clinical narrative: Patient called and left a phone message for the VP of a clinic on 09/30/2021.   I was able to retunr his call on 09/30/2021 at 6pm.  He stated that after receiving the 1st COVID  vaccine he left the event place and got a cup of coffee.  He said the coffee didn't taste the same as usual, and this was his first symptom.  He had no other symptoms, so he returned and took at 2nd COVID vaccine on 02/26/21.   He stated approximately 30 days after the 2nd vaccine his symptoms began exacerbating.  He experienced loss of appetite, eventually losing more than 12 pounds.   He reported 30 days after the 2nd vaccine he had trouble sleeping at night, crazy dreams.  He also said he had a burning sensation from his chest down to his pelvic area- an intense internal heat, and he was not febrile by the thermometer.   He states he has spent thousands of dollars going to doctors and specialists and he still doesn't have an answer to what is going on.  He told me all of his tests and lab works have been negative- he could not tell me what tests or labs he had done.  He did state he is feeling better.  I told him not to take the 3rd booster vaccine until he had been cleared to do so by his physician.   I also encouraged him to report this on VAERS and provided him with the website address.   I have alerted the Quality person of this event.  The evens that patient received were at our system's hospitals community events.
Age: 56.0
Sex: F
Vaccine: FLUR4
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Extreme erythema and swelling of lower arm area
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Headache, Pain, Pyrexia
Clinical narrative: Body ache, Headache, low fever, tired.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Dizziness, Fatigue, Presyncope
Clinical narrative: Dizziness, fatigue, cough, and COVID positive on 9/30/21.    The patient is a 72 yo male who presents with dizziness and COVID 19 infection.   Comorbidities include HTN, hyperlipidemia, prostate cancer s/p radiation (completed May 2019 followed by androgen supression therapy completed Oct 2019, last PSA <0.1 on 5/10/21), peripheral neuropathy, depression, anxiety, and prior ischemic stroke (Oct 2020, no residual deficits) with left carotid artery occlusion s/p right carotid stent placement on 11/2/20. Prior COVID 19 vaccine (Pfizer) completed on 2/24/21.    Patient presented to ED due to episode of near syncope earlier today. Patient reported feeling tired, having a cough, and had planned to have a booster dose of vaccine but has not been able to do it yet. While walking to the bathroom this morning, he felt dizzy, had to lower himself to the floor, was diaphoretic, and slow to respond. During this episode patient denied any chest pain, shortness of breath, palpitations, loss of consciousness, and seizures.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Dizziness, fatigue, cough, and COVID positive on 9/30/21.    The patient is a 72 yo male who presents with dizziness and COVID 19 infection.   Comorbidities include HTN, hyperlipidemia, prostate cancer s/p radiation (completed May 2019 followed by androgen supression therapy completed Oct 2019, last PSA <0.1 on 5/10/21), peripheral neuropathy, depression, anxiety, and prior ischemic stroke (Oct 2020, no residual deficits) with left carotid artery occlusion s/p right carotid stent placement on 11/2/20. Prior COVID 19 vaccine (Pfizer) completed on 2/24/21.    Patient presented to ED due to episode of near syncope earlier today. Patient reported feeling tired, having a cough, and had planned to have a booster dose of vaccine but has not been able to do it yet. While walking to the bathroom this morning, he felt dizzy, had to lower himself to the floor, was diaphoretic, and slow to respond. During this episode patient denied any chest pain, shortness of breath, palpitations, loss of consciousness, and seizures.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Erythema, Mobility decreased, Peripheral swelling, Pruritus, Rash
Clinical narrative: 18 hrs after shot site local rash, redness and itching -10am. By 11am upper arm significantly swollen, bright red, tight skin hot to the touch. School called me. Ice was applied, markings made to see if swelling continued. Emailed Dr. photos and timeline regarding reaction and seeking advice. Dr. said ice and Zyrtec were recommended and he would check with Allergist. Swelling continued resulting in limited arm movements. 9/29/2021?7pm; Claritin was given with no result; 9/30/21 8am Zyrtec given as recommendation from pediatrician. Received follow up email from Dr. that Allergist said Zyrtec likely to not effect this kind of allergic reaction.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Skin tightness
Clinical narrative: 18 hrs after shot site local rash, redness and itching -10am. By 11am upper arm significantly swollen, bright red, tight skin hot to the touch. School called me. Ice was applied, markings made to see if swelling continued. Emailed Dr. photos and timeline regarding reaction and seeking advice. Dr. said ice and Zyrtec were recommended and he would check with Allergist. Swelling continued resulting in limited arm movements. 9/29/2021?7pm; Claritin was given with no result; 9/30/21 8am Zyrtec given as recommendation from pediatrician. Received follow up email from Dr. that Allergist said Zyrtec likely to not effect this kind of allergic reaction.
Age: 54.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Injection site pain, Pain
Clinical narrative: Cannot move arm without pain. No redness or warmth at the site but persistent pain that worsens with movement
Age: 54.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Injected limb mobility decreased
Clinical narrative: Cannot move arm without pain. No redness or warmth at the site but persistent pain that worsens with movement
Age: 54.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Injection site pain, Pain
Clinical narrative: Patient states that she is unable to raise her arm above her head ever since she received her flu shot on 9/23/21
Age: 54.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Injected limb mobility decreased
Clinical narrative: Patient states that she is unable to raise her arm above her head ever since she received her flu shot on 9/23/21
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Oropharyngeal discomfort
Clinical narrative: 48 yo female with PMHx Churg-Strauss and allergy to rituximab, now with vaccine reaction.  Pt with remote h/o rituximab reaction p/w throat swelling, itching, wheezing.  Infusion d/c'ed and pt given medication.  Since then, has been treated with nucala w/o issue.   Has h/o multiple food reactions, suspected sulfite sensitivity.  Pt was seen by her allergist, who cleared her for the COVID vaccine as she tolerates nucala (which has polysorbate 80 as well).   Today, pt was given the Pfizer vaccine at 5:30 PM, and within 15 minutes felt LH and vague throat discomfort.  Denies throat closing or itching.   +LH but does not feel like she will pass out.  No vertigo.     No face/tongue/lip swelling/itching, stridor, wheezing, SOB. No CP, palp, diaphoresis, N/V, abd pain, diarrhea. Pt given benadryl 50 at 6:05 PM with some mild improvement.   Pt also on chronic daily steroids, which she took this AM.      VS: T 98.2, HR 80s, R 16, BP 150s/90s, SaO2 99% RA.  Gen: WDWN HEENT: NCAT, sclera anicteric and w/o injection, MMM, OP clear.   Neck: supple, good ROM CV: RRR, S1, S2. No m/r/g Pulm: CTAB.  No wheezes or crackles.  No stridor Abd: S, NT, ND. NABS.  No rebound or guarding Extr: no c/c/e Skin: no rashes Neuro: A&Ox3.  No focal deficits   A/P: 48 yo female with PMHx Churg-Strauss and allergy to rituximab, now with vaccine reaction, p/w vague throat discomfort and LH. No e/o anaphylaxis, however as sxs persist despite benadryl (and pt on baseline steroids), feel that pt warrants prolonged observation that cannot be done in clinic.  Monitor for s/sx anaphylaxis, epipen if develops. EMS called and pt transported to the ED. While in ER, pt given dex IM, monitored for a few hours and discharged with instructions to f/u with her allergist.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Migraine, Myalgia, Pain, Pyrexia
Clinical narrative: Fever 101.1, chills,  body/muscle aches and migraine.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death
Clinical narrative: COVID infection. Specimen collected on 8/16/21. Patient died on 9/4/21.
Age: 21.0
Sex: M
Vaccine: HEP, HEP
Symptoms: Dyspnoea, Seizure, Urticaria
Clinical narrative: Hives, SOB, and 30 second seizure.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris, Dizziness postural, Headache, Pyrexia
Clinical narrative: Started  running high fever and headache at about 9:45pm on the date of vaccine 9/29/21 still running a fever today 10/01/21. On. 9/30/21 couldn't get out of bed except to use the bathroom due to headache and fever. 10/01/21 I still have slight headache fever has reduced. However I am dizzy anytime I stand for any amount of time I have started to have pain around my heart area as well.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests normal, Influenza like illness, Pyrexia, Rash, Tinnitus
Clinical narrative: Tinnitus in right ear, constant since two days later, when I had fever/flu-like symptoms.  Less serious, but I also got Covid arm with both doses.  The rash was more significant for the first dose.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Tinnitus in right ear, constant since two days later, when I had fever/flu-like symptoms.  Less serious, but I also got Covid arm with both doses.  The rash was more significant for the first dose.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymphadenopathy-L neck swelled up and lymph nodes palpable just above the collarbone on the side of neck. Injection was given in  the left arm.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Blood thyroid stimulating hormone, Goitre, Inflammation, Weight increased
Clinical narrative: Severe weight gain despite no known cause, inflammation with pain in all joints, thyroid enlargement, changes in TSH despite no symptoms in months prior - Hashimotos was controlled
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Patient received Pfizer vaccine with 1st dose on 03/11/2021 and 2nd dose on 04/01/2021 Per ED Note: Patient is an 83-year-old male with past medical history coronary artery disease and coronary artery bypass graft, diabetes mellitus, hyperlipidemia and hypertension presenting to emergency department chief complaint of difficulty breathing.  Patient states that his symptoms began approximately 1 week ago and subsequently tested positive for COVID-19 viral illness.  He denies any associated chest pain.  He states that the shortness of breath has been worsening since the onset of symptoms and is constant, no significant improvement at rest.  He is not normally on home oxygen.  Patient denies fever, chills, headache, blurry vision, nausea, vomiting, diarrhea, chest pain, abdominal pain, numbness, weakness or tingling in his extremities.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Balance disorder, Dizziness, Feeling abnormal, Nausea
Clinical narrative: off balance, light headed, dizzy, vertigo, brain fog, slight nausea, severe neck/shoulder pain, racing heart at times, blurry vision, joint pain in hands/fingers.  I am afraid to take the 2nd dose which I am scheduled for today.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Palpitations, Vertigo, Vision blurred
Clinical narrative: off balance, light headed, dizzy, vertigo, brain fog, slight nausea, severe neck/shoulder pain, racing heart at times, blurry vision, joint pain in hands/fingers.  I am afraid to take the 2nd dose which I am scheduled for today.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chills, Diarrhoea, Dizziness, Nausea
Clinical narrative: fever,  nausea vomiting diarrhea,   chills,  dizziness anxiety,  48 hours
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: fever,  nausea vomiting diarrhea,   chills,  dizziness anxiety,  48 hours
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood culture, Blood lactic acid, Blood sodium decreased, Blood test, COVID-19
Clinical narrative: Patient is seen upon arrival to emergency department.  Vitals are reviewed and noted for a low-grade temp of 99.6 as well as a heart rate of 101.  Patient is 95% on room air.  Patient is extremely hard of hearing, and left his hearing aids at home.  His daughter at bedside.  Patient will have an IV established, blood work performed, chest x-ray and a rapid Covid test for further evaluation.  Patient's labs are reviewed, noted for hemoglobin of 7.9, is his baseline.  WBCs are low at 3.5.  Given this blood cultures and lactate are ordered.  His sodium is noted to be low at 126.  Chest x-ray shows evidence of right lower lobe pneumonia.  Patient will be given Rocephin 1 g IV and azithromycin 500 mg IV.  He is also given Decadron 10 mg IV. Rapid Covid test is positive.  Patient and daughter at bedside have been updated of this.  Patient has been continued to be monitored in the ER, and his oxygen does go down to 87% while he is at rest.  Given this, and patient's chest x-ray findings of pneumonia and Covid, I did offer admission, and they are agreeable to this.
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray abnormal, Haemoglobin decreased, Oxygen saturation decreased, Pneumonia, Pyrexia
Clinical narrative: Patient is seen upon arrival to emergency department.  Vitals are reviewed and noted for a low-grade temp of 99.6 as well as a heart rate of 101.  Patient is 95% on room air.  Patient is extremely hard of hearing, and left his hearing aids at home.  His daughter at bedside.  Patient will have an IV established, blood work performed, chest x-ray and a rapid Covid test for further evaluation.  Patient's labs are reviewed, noted for hemoglobin of 7.9, is his baseline.  WBCs are low at 3.5.  Given this blood cultures and lactate are ordered.  His sodium is noted to be low at 126.  Chest x-ray shows evidence of right lower lobe pneumonia.  Patient will be given Rocephin 1 g IV and azithromycin 500 mg IV.  He is also given Decadron 10 mg IV. Rapid Covid test is positive.  Patient and daughter at bedside have been updated of this.  Patient has been continued to be monitored in the ER, and his oxygen does go down to 87% while he is at rest.  Given this, and patient's chest x-ray findings of pneumonia and Covid, I did offer admission, and they are agreeable to this.
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, White blood cell count decreased
Clinical narrative: Patient is seen upon arrival to emergency department.  Vitals are reviewed and noted for a low-grade temp of 99.6 as well as a heart rate of 101.  Patient is 95% on room air.  Patient is extremely hard of hearing, and left his hearing aids at home.  His daughter at bedside.  Patient will have an IV established, blood work performed, chest x-ray and a rapid Covid test for further evaluation.  Patient's labs are reviewed, noted for hemoglobin of 7.9, is his baseline.  WBCs are low at 3.5.  Given this blood cultures and lactate are ordered.  His sodium is noted to be low at 126.  Chest x-ray shows evidence of right lower lobe pneumonia.  Patient will be given Rocephin 1 g IV and azithromycin 500 mg IV.  He is also given Decadron 10 mg IV. Rapid Covid test is positive.  Patient and daughter at bedside have been updated of this.  Patient has been continued to be monitored in the ER, and his oxygen does go down to 87% while he is at rest.  Given this, and patient's chest x-ray findings of pneumonia and Covid, I did offer admission, and they are agreeable to this.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Laboratory test
Clinical narrative: COVID infection. Specimen collected 8/19/21. Hospitalized on 8/22/21. Still hospitalized at this time.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Patient states she had a sudden onset of chills and severe quivering. Contacted 911 from fear of serious health issue. Temperature was 96.8 F, blood pressure was 100/100
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Soreness (slight)  at injection site
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vertigo
Clinical narrative: I felt extremely fatigued for about 24 hours starting around 6 p.m. the day of the injectin and lasting until around 6 p.m. the following day.   I also started having vertigo occuring intermittently for up to 15 mintues at a time.  As of today, 10/1/2021, I have experienced the vertigo every day since I received the injectin on 9/19/2021.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Upper Torso (front and back), lower torso (front and back), and upper arms are covered in hives. Some itch more than others.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Mood swings, Myalgia, Pyrexia
Clinical narrative: the third shoot  had more adverse effects than the previous two: Fever, severe muscle back all over my body, mood swing (like froggy bain) fatigue Time frame  3 days for all
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Antinuclear antibody negative, Arthralgia, C-reactive protein normal, Full blood count normal, Joint swelling
Clinical narrative: JOINT PAIN BILAT,  SHOULDER/ELBOWS/KNEES/LEFT ANKLE/LEFT BASE OF THUMB-WRIST. INTERMITTENT  SWELLING OF ALL THESE MENTIONED JOINTS NO ERYTHEMA OR WARMTH
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, Rheumatoid factor increased
Clinical narrative: JOINT PAIN BILAT,  SHOULDER/ELBOWS/KNEES/LEFT ANKLE/LEFT BASE OF THUMB-WRIST. INTERMITTENT  SWELLING OF ALL THESE MENTIONED JOINTS NO ERYTHEMA OR WARMTH
Age: 92.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, Laboratory test
Clinical narrative: COVID infection. Specimen collected on 8/19/21. Patient died on 8/24/21.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Facial paralysis, SARS-CoV-2 test positive, Sluggishness
Clinical narrative: This is a 66-year-old African American female with past medical history of hypertension, multiple sclerosis, dementia, functional quadriplegia secondary to multiple sclerosis.     She came to the hospital with a chief complaint of right-sided facial droop which was noticed it 1:30 p.m. by the patient's daughter.  All the symptoms where going on a little bit earlier as well.  It was noted that the patient was more sluggish than usual baseline.   Other than that the patient cannot talk much due to advanced multiple sclerosis and bedbound status with functional quadriplegia.  History taking was limited from the patient.  It was reported that the patient's daughter was tested positive for COVID-19 and she was quarantine Ng by herself.  Patient was being cared for by home health nurses, PT and occupational therapist.  They have been testing the patient almost every day for COVID-19.  Today finally her test came back positive for COVID-19 at home.  Before all the previous tests were negative for COVID-19.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Heart rate increased, Pleurisy, Pyrexia, Syncope
Clinical narrative: syncope, elevated heart rate, fever 99-102, chest pain, began overnight.  Was evaluated at Medical Center ER the following day, diagnosed with pleurisy
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis, Nausea, Pyrexia
Clinical narrative: Sustained fever of 99.5-101 beginning at 1am,  around  17 hours after my shot. I began taking 1 Tylenol and 1 ibuprofen beginning at 8pm last night every 3 hours. My fever persists through the meds. I?m pouring in sweat sitting by a fan and eating ice chips after taking a cold shower. I can?t control the fever. I feel nauseous and like I?m going to pass out
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, Laboratory test
Clinical narrative: COVID infection. Specimen collected on 8/11/21. Patient died on 8/13/21.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Pain, Presyncope, Pyrexia, Rash
Clinical narrative: Rash on chest, 2 near syncopal episodes alond with  fever and bodyaches all occured about  24 hours after vacinnation.   one week later hair stated falling out.  employee com[plains of daily fever and continued hair loss. as of  10-1-2021
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Myalgia, Pain in extremity
Clinical narrative: Arm pain, muscle aches, lethargy all lasting ~24 hours